We have previously demonstrated that the pretherapeutic (or untreated) serum interleukin-8 (sIL-8) levels are elevated in about half of patients with locally advanced gastric cancer, and elevated sIL-8 levels are associated with Lauren classification, T staging and chemoresistance [26]. The gene discussed is CXCL8; the disease is gastric cancer.